Results 111 to 120 of about 685 (181)

Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study. [PDF]

Sci Rep, 2023
Ab Rahman N, Lim MT, Lee FY, Wo WK, Yeoh HS, Peariasamy KM, Sivasampu S, SAFECOVAC Study Group.   +7 more
europepmc   +1 more source

Sukuk

Turkish Journal of Islamic Economics, 2014
openaire   +1 more source

In search of hedges and safe havens during the COVID-19 pandemic: Gold versus Bitcoin, oil, and oil uncertainty. [PDF]

Q Rev Econ Finance, 2022
Al-Nassar NS, Boubaker S, Chaibi A, Makram B.   +3 more
europepmc   +1 more source

Recombinant Bacillus subtilis spores expressing SARS-CoV-2 spike protein induced humoral, mucosal, and cellular immunity in mice. [PDF]

Sci Rep
Hazan A, Saperi AA, Zulkifli N, MatRahim NA, Tiong V, Lee HY, AbuBakar S.   +6 more
europepmc   +1 more source

Islamic finance in Russia: A market review and the legal environment. [PDF]

Glob Financ J, 2020
Kalimullina M.
europepmc   +1 more source

A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol. [PDF]

Front Pharmacol, 2022
Ab Rahman N, Lim MT, Lee FY, Ong SM, Peariasamy KM, Sivasampu S.   +5 more
europepmc   +1 more source

Green Investments: A Luxury Good or a Financial Necessity?

, 2021
Yousaf I, Suleman T, Demirer R.
europepmc   +1 more source

Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities. [PDF]

PLoS Negl Trop Dis
Kafle A, Suttiprapa S, Muhammad M, Tenorio JCB, Mahato RK, Sahimin N, Loong SK.   +6 more
europepmc   +1 more source

What factors affecting investment decision? The moderating role of fintech self-efficacy. [PDF]

PLoS One
Che Hassan N, Abdul-Rahman A, Ab Hamid SN, Mohd Amin SI.   +3 more
europepmc   +1 more source